Q2 figures pre-announced OrganoClick reported sales of SEK 30m (-23% y-o-y) and EBIT of -4.
Redeye updates its estimates and valuation following Tradedoubler’s Q2 2025 report.
Redeye interviews Lagercrantz’s CEO, Jörgen Wigh. We discuss the company’s solid Q1 figures, recent ...
Redeye comments on Camurus' Q2 report 2025, which was in line with our estimates on a constant curre...
Redeye provides an update following Truecaller’s Q2 2025 report, which came in somewhat softer than ...
Paving services delivering Infrea delivered a mixed Q2, with sales 5% above ABGSCe.
Redeye is making some positive adjustments to our forecasts and valuation following a stronger than ...
Another impressive margin lift Nolato reported Q2 EBITA 5% and 7% above ABGSCe and IR consensus, res...
Solid Q2, UK is the star of the show We saw signs of improvement for both Svedbergs and Roper Rhodes...
The market remains challenging As in recent quarters, Ework's Q2 was affected by a weak market, with...
Q2 results Prevas reported a weaker-than-expected Q2'25, with sales of SEK 409m, up 3% y-o-y (4% bel...
Q2 results Q2 sales were SEK 3,601m (+1% vs. ABGSCe 3,550m), -13% y-o-y.
Redeye provides and initial comment on the Q2 2025 report from Safeture, which showed negative ARR g...
Redeye comments on Arise’s Q2 report, which saw higher production than expected, driving the segment...
Q2 details Infrea delivered a mixed report with higher sales and lower adj.
